36756311000001105: Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\UK product\Virtual medicinal product\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\UK product\Virtual therapeutic moiety\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\UK product\Virtual therapeutic moiety\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\UK product\Trade family\Trazimera\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
\Medicinal product\Product manufactured as parenteral dose form\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Mar 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

112686901000001118 Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

112687001000001119 Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	VMP prescribing status (attribute)	Caution - AMP level prescribing advised	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator	EMA (European Medicines Agency) monitoring	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Is a	Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has manufactured dose form	Powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has basis of strength substance	Trastuzumab	true	Inferred relationship	Existential restriction modifier	1
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has presentation strength numerator value	150	false	Inferred relationship	Existential restriction modifier	1
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has presentation strength denominator unit	Vial	true	Inferred relationship	Existential restriction modifier	1
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has precise active ingredient	Trastuzumab	true	Inferred relationship	Existential restriction modifier	1
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has unit of presentation	Vial	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	false	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has specific active ingredient	Trastuzumab	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Is a	Trazimera	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) 1 vial	Has AMP	True	Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
112686901000001118	Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
112687001000001119	Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module